|
Reference : Rosiglitazone: to be or not to be? |
|
| | |
| | Scientific journals : Article | |
| | Human health sciences : Pharmacy, pharmacology & toxicology Human health sciences : Endocrinology, metabolism & nutrition
| |
| | http://hdl.handle.net/2268/17428 | |
| | |
| Rosiglitazone: to be or not to be? |
| English |
| Scheen, André [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >] |
| 2009 |
| Diabetologia |
| 52 |
| 7 |
| 1448-50 |
| 1432-0428 |
| Germany |
| http://hdl.handle.net/2268/17428 |
| 10.1007/s00125-009-1358-z |
| http://www.thelancet.com |
| The original publication is available at www.springerlink.com |
| File(s) associated to this reference | |
|
Fulltext file(s):
| |
| | |
All documents in ORBi are protected by a user license.